Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPE-PREVENTION: Icosapent Ethyl for Vascular Regenerative Cell Exhaustion
NCT04562467Phase 4Completed
- Sponsor
- Canadian Medical and Surgical Knowledge Translation Research Group
- Start
- Sep 2020
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omega-3-acid triglycerides in hypertriglyceridemia, cardiovascular disease (CVD), sponsored by Canadian Medical and Surgical Knowledge Translation Research Group. Started Sep 2020; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
hypertriglyceridemiacardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT04562467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04562467.